"","title","geo_accession","status","submission_date","last_update_date","type","channel_count","source_name_ch1","organism_ch1","characteristics_ch1","characteristics_ch1.1","characteristics_ch1.2","characteristics_ch1.3","characteristics_ch1.4","characteristics_ch1.5","treatment_protocol_ch1","molecule_ch1","extract_protocol_ch1","label_ch1","label_protocol_ch1","taxid_ch1","hyb_protocol","scan_protocol","description","data_processing","platform_id","contact_name","contact_email","contact_laboratory","contact_department","contact_institute","contact_address","contact_city","contact_state","contact_zip/postal_code","contact_country","supplementary_file","data_row_count","age:ch1","collection timepoint:ch1","diagnosis:ch1","histology:ch1","Stage:ch1","tissue:ch1"
"GSM2108823","miRS_4_1","GSM2108823","Public on Mar 19 2017","Apr 05 2016","Mar 19 2017","RNA","1","serum, preoperative","Homo sapiens","tissue: blood serum","collection timepoint: preoperative","diagnosis: Ovarian cancer","histology: serous adenocarcinoma","Stage: IIc","age: 52","Blood samples were obtained just before operation (preoperative) or after 1 month (postoperative) and centrifuged for 10 minutes at 3,000 r.p.m. to separate serum within 24 hours.","total RNA","Total RNA was isolated from tissues using TRIzol Reagent (nitrogen) and purified using SV Total RNA Isolation System (Promega)","Cy3","cRNA was amplified and labelled using a Low input Quick Amp Labelling Kit (Agilent Technologies).","9606","cRNA was hybridized to a 60K 60-mer oligomicroarray (SurePrint Human miRNA Microarray Release 16.0, 8x60K; Agilent Technologies) according to the manufacturer's instructions.","The hybridized microarray slides were scanned using an Agilent scanner. The relative hybridization intensities and background hybridization values were calculated using Feature Extraction Software version 9.5.1.1 (Agilent Technologies).","Progression free survival ≥ 12 months","The scanned images were analyzed with Feature Extraction Software 9.5.1.1 (Agilent) using default parameters to obtain background subtracted and spatially detrended Processed Signal intensities.  The raw signal intensities and flags for each probe were calculated from the hybridization intensities and spot information according to the procedures recommended by Agilent Technologies using the Flag criteria in the GeneSpring Software. P = Detected; A = Not detected.","GPL16770","Kohei,,Miyata","slackomit@gmail.com","Obstetrics and Gynecology","Faculty of Medicine","Fukuoka University","7-45-1 Nanakuma, Jonan-ku","Fukuoka","FUkuoka","814-0180","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2108nnn/GSM2108823/suppl/GSM2108823_253118113953_S01_miRNA_107_Sep09_1_4.txt.gz","1347","52","preoperative","Ovarian cancer","serous adenocarcinoma","IIc","blood serum"
"GSM2108824","miRS_4_2","GSM2108824","Public on Mar 19 2017","Apr 05 2016","Mar 19 2017","RNA","1","serum, postoperative","Homo sapiens","tissue: blood serum","collection timepoint: postoperative","diagnosis: Ovarian cancer","histology: serous adenocarcinoma","Stage: IIc","age: 52","Blood samples were obtained just before operation (preoperative) or after 1 month (postoperative) and centrifuged for 10 minutes at 3,000 r.p.m. to separate serum within 24 hours.","total RNA","Total RNA was isolated from tissues using TRIzol Reagent (nitrogen) and purified using SV Total RNA Isolation System (Promega)","Cy3","cRNA was amplified and labelled using a Low input Quick Amp Labelling Kit (Agilent Technologies).","9606","cRNA was hybridized to a 60K 60-mer oligomicroarray (SurePrint Human miRNA Microarray Release 16.0, 8x60K; Agilent Technologies) according to the manufacturer's instructions.","The hybridized microarray slides were scanned using an Agilent scanner. The relative hybridization intensities and background hybridization values were calculated using Feature Extraction Software version 9.5.1.1 (Agilent Technologies).","Progression free survival ≥ 12 months","The scanned images were analyzed with Feature Extraction Software 9.5.1.1 (Agilent) using default parameters to obtain background subtracted and spatially detrended Processed Signal intensities.  The raw signal intensities and flags for each probe were calculated from the hybridization intensities and spot information according to the procedures recommended by Agilent Technologies using the Flag criteria in the GeneSpring Software. P = Detected; A = Not detected.","GPL16770","Kohei,,Miyata","slackomit@gmail.com","Obstetrics and Gynecology","Faculty of Medicine","Fukuoka University","7-45-1 Nanakuma, Jonan-ku","Fukuoka","FUkuoka","814-0180","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2108nnn/GSM2108824/suppl/GSM2108824_253118113953_S01_miRNA_107_Sep09_2_1.txt.gz","1347","52","postoperative","Ovarian cancer","serous adenocarcinoma","IIc","blood serum"
"GSM2108825","miRS_5_1","GSM2108825","Public on Mar 19 2017","Apr 05 2016","Mar 19 2017","RNA","1","serum, preoperative","Homo sapiens","tissue: blood serum","collection timepoint: preoperative","diagnosis: Ovarian cancer","histology: serous adenocarcinoma","Stage: IIIc","age: 57","Blood samples were obtained just before operation (preoperative) or after 1 month (postoperative) and centrifuged for 10 minutes at 3,000 r.p.m. to separate serum within 24 hours.","total RNA","Total RNA was isolated from tissues using TRIzol Reagent (nitrogen) and purified using SV Total RNA Isolation System (Promega)","Cy3","cRNA was amplified and labelled using a Low input Quick Amp Labelling Kit (Agilent Technologies).","9606","cRNA was hybridized to a 60K 60-mer oligomicroarray (SurePrint Human miRNA Microarray Release 16.0, 8x60K; Agilent Technologies) according to the manufacturer's instructions.","The hybridized microarray slides were scanned using an Agilent scanner. The relative hybridization intensities and background hybridization values were calculated using Feature Extraction Software version 9.5.1.1 (Agilent Technologies).","Progression free survival < 12 months","The scanned images were analyzed with Feature Extraction Software 9.5.1.1 (Agilent) using default parameters to obtain background subtracted and spatially detrended Processed Signal intensities.  The raw signal intensities and flags for each probe were calculated from the hybridization intensities and spot information according to the procedures recommended by Agilent Technologies using the Flag criteria in the GeneSpring Software. P = Detected; A = Not detected.","GPL16770","Kohei,,Miyata","slackomit@gmail.com","Obstetrics and Gynecology","Faculty of Medicine","Fukuoka University","7-45-1 Nanakuma, Jonan-ku","Fukuoka","FUkuoka","814-0180","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2108nnn/GSM2108825/suppl/GSM2108825_253118113953_S01_miRNA_107_Sep09_2_2.txt.gz","1347","57","preoperative","Ovarian cancer","serous adenocarcinoma","IIIc","blood serum"
"GSM2108826","miRS_5_2","GSM2108826","Public on Mar 19 2017","Apr 05 2016","Mar 19 2017","RNA","1","serum, postoperative","Homo sapiens","tissue: blood serum","collection timepoint: postoperative","diagnosis: Ovarian cancer","histology: serous adenocarcinoma","Stage: IIIc","age: 57","Blood samples were obtained just before operation (preoperative) or after 1 month (postoperative) and centrifuged for 10 minutes at 3,000 r.p.m. to separate serum within 24 hours.","total RNA","Total RNA was isolated from tissues using TRIzol Reagent (nitrogen) and purified using SV Total RNA Isolation System (Promega)","Cy3","cRNA was amplified and labelled using a Low input Quick Amp Labelling Kit (Agilent Technologies).","9606","cRNA was hybridized to a 60K 60-mer oligomicroarray (SurePrint Human miRNA Microarray Release 16.0, 8x60K; Agilent Technologies) according to the manufacturer's instructions.","The hybridized microarray slides were scanned using an Agilent scanner. The relative hybridization intensities and background hybridization values were calculated using Feature Extraction Software version 9.5.1.1 (Agilent Technologies).","Progression free survival < 12 months","The scanned images were analyzed with Feature Extraction Software 9.5.1.1 (Agilent) using default parameters to obtain background subtracted and spatially detrended Processed Signal intensities.  The raw signal intensities and flags for each probe were calculated from the hybridization intensities and spot information according to the procedures recommended by Agilent Technologies using the Flag criteria in the GeneSpring Software. P = Detected; A = Not detected.","GPL16770","Kohei,,Miyata","slackomit@gmail.com","Obstetrics and Gynecology","Faculty of Medicine","Fukuoka University","7-45-1 Nanakuma, Jonan-ku","Fukuoka","FUkuoka","814-0180","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2108nnn/GSM2108826/suppl/GSM2108826_253118113953_S01_miRNA_107_Sep09_2_3.txt.gz","1347","57","postoperative","Ovarian cancer","serous adenocarcinoma","IIIc","blood serum"
"GSM2108827","miRS_6_1","GSM2108827","Public on Mar 19 2017","Apr 05 2016","Mar 19 2017","RNA","1","serum, preoperative","Homo sapiens","tissue: blood serum","collection timepoint: preoperative","diagnosis: Ovarian cancer","histology: serous adenocarcinoma","Stage: IV","age: 76","Blood samples were obtained just before operation (preoperative) or after 1 month (postoperative) and centrifuged for 10 minutes at 3,000 r.p.m. to separate serum within 24 hours.","total RNA","Total RNA was isolated from tissues using TRIzol Reagent (nitrogen) and purified using SV Total RNA Isolation System (Promega)","Cy3","cRNA was amplified and labelled using a Low input Quick Amp Labelling Kit (Agilent Technologies).","9606","cRNA was hybridized to a 60K 60-mer oligomicroarray (SurePrint Human miRNA Microarray Release 16.0, 8x60K; Agilent Technologies) according to the manufacturer's instructions.","The hybridized microarray slides were scanned using an Agilent scanner. The relative hybridization intensities and background hybridization values were calculated using Feature Extraction Software version 9.5.1.1 (Agilent Technologies).","Progression free survival < 12 months","The scanned images were analyzed with Feature Extraction Software 9.5.1.1 (Agilent) using default parameters to obtain background subtracted and spatially detrended Processed Signal intensities.  The raw signal intensities and flags for each probe were calculated from the hybridization intensities and spot information according to the procedures recommended by Agilent Technologies using the Flag criteria in the GeneSpring Software. P = Detected; A = Not detected.","GPL16770","Kohei,,Miyata","slackomit@gmail.com","Obstetrics and Gynecology","Faculty of Medicine","Fukuoka University","7-45-1 Nanakuma, Jonan-ku","Fukuoka","FUkuoka","814-0180","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2108nnn/GSM2108827/suppl/GSM2108827_253118113953_S01_miRNA_107_Sep09_2_4.txt.gz","1347","76","preoperative","Ovarian cancer","serous adenocarcinoma","IV","blood serum"
"GSM2108828","miRS_6_2","GSM2108828","Public on Mar 19 2017","Apr 05 2016","Mar 19 2017","RNA","1","serum, postoperative","Homo sapiens","tissue: blood serum","collection timepoint: postoperative","diagnosis: Ovarian cancer","histology: serous adenocarcinoma","Stage: IV","age: 76","Blood samples were obtained just before operation (preoperative) or after 1 month (postoperative) and centrifuged for 10 minutes at 3,000 r.p.m. to separate serum within 24 hours.","total RNA","Total RNA was isolated from tissues using TRIzol Reagent (nitrogen) and purified using SV Total RNA Isolation System (Promega)","Cy3","cRNA was amplified and labelled using a Low input Quick Amp Labelling Kit (Agilent Technologies).","9606","cRNA was hybridized to a 60K 60-mer oligomicroarray (SurePrint Human miRNA Microarray Release 16.0, 8x60K; Agilent Technologies) according to the manufacturer's instructions.","The hybridized microarray slides were scanned using an Agilent scanner. The relative hybridization intensities and background hybridization values were calculated using Feature Extraction Software version 9.5.1.1 (Agilent Technologies).","Progression free survival < 12 months","The scanned images were analyzed with Feature Extraction Software 9.5.1.1 (Agilent) using default parameters to obtain background subtracted and spatially detrended Processed Signal intensities.  The raw signal intensities and flags for each probe were calculated from the hybridization intensities and spot information according to the procedures recommended by Agilent Technologies using the Flag criteria in the GeneSpring Software. P = Detected; A = Not detected.","GPL16770","Kohei,,Miyata","slackomit@gmail.com","Obstetrics and Gynecology","Faculty of Medicine","Fukuoka University","7-45-1 Nanakuma, Jonan-ku","Fukuoka","FUkuoka","814-0180","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2108nnn/GSM2108828/suppl/GSM2108828_253118111611_S01_miRNA_107_Sep09_1_1.txt.gz","1347","76","postoperative","Ovarian cancer","serous adenocarcinoma","IV","blood serum"
"GSM2108829","miRC_1_1","GSM2108829","Public on Mar 19 2017","Apr 05 2016","Mar 19 2017","RNA","1","serum, preoperative","Homo sapiens","tissue: blood serum","collection timepoint: preoperative","diagnosis: Ovarian cancer","histology: serous adenocarcinoma + clear cell carcinoma","Stage: IV","age: 62","Blood samples were obtained just before operation (preoperative) or after 1 month (postoperative) and centrifuged for 10 minutes at 3,000 r.p.m. to separate serum within 24 hours.","total RNA","Total RNA was isolated from tissues using TRIzol Reagent (nitrogen) and purified using SV Total RNA Isolation System (Promega)","Cy3","cRNA was amplified and labelled using a Low input Quick Amp Labelling Kit (Agilent Technologies).","9606","cRNA was hybridized to a 60K 60-mer oligomicroarray (SurePrint Human miRNA Microarray Release 16.0, 8x60K; Agilent Technologies) according to the manufacturer's instructions.","The hybridized microarray slides were scanned using an Agilent scanner. The relative hybridization intensities and background hybridization values were calculated using Feature Extraction Software version 9.5.1.1 (Agilent Technologies).","Progression free survival < 12 months","The scanned images were analyzed with Feature Extraction Software 9.5.1.1 (Agilent) using default parameters to obtain background subtracted and spatially detrended Processed Signal intensities.  The raw signal intensities and flags for each probe were calculated from the hybridization intensities and spot information according to the procedures recommended by Agilent Technologies using the Flag criteria in the GeneSpring Software. P = Detected; A = Not detected.","GPL16770","Kohei,,Miyata","slackomit@gmail.com","Obstetrics and Gynecology","Faculty of Medicine","Fukuoka University","7-45-1 Nanakuma, Jonan-ku","Fukuoka","FUkuoka","814-0180","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2108nnn/GSM2108829/suppl/GSM2108829_253118111611_S01_miRNA_107_Sep09_1_2.txt.gz","1347","62","preoperative","Ovarian cancer","serous adenocarcinoma + clear cell carcinoma","IV","blood serum"
"GSM2108830","miRC_1_2","GSM2108830","Public on Mar 19 2017","Apr 05 2016","Mar 19 2017","RNA","1","serum, postoperative","Homo sapiens","tissue: blood serum","collection timepoint: postoperative","diagnosis: Ovarian cancer","histology: serous adenocarcinoma + clear cell carcinoma","Stage: IV","age: 62","Blood samples were obtained just before operation (preoperative) or after 1 month (postoperative) and centrifuged for 10 minutes at 3,000 r.p.m. to separate serum within 24 hours.","total RNA","Total RNA was isolated from tissues using TRIzol Reagent (nitrogen) and purified using SV Total RNA Isolation System (Promega)","Cy3","cRNA was amplified and labelled using a Low input Quick Amp Labelling Kit (Agilent Technologies).","9606","cRNA was hybridized to a 60K 60-mer oligomicroarray (SurePrint Human miRNA Microarray Release 16.0, 8x60K; Agilent Technologies) according to the manufacturer's instructions.","The hybridized microarray slides were scanned using an Agilent scanner. The relative hybridization intensities and background hybridization values were calculated using Feature Extraction Software version 9.5.1.1 (Agilent Technologies).","Progression free survival < 12 months","The scanned images were analyzed with Feature Extraction Software 9.5.1.1 (Agilent) using default parameters to obtain background subtracted and spatially detrended Processed Signal intensities.  The raw signal intensities and flags for each probe were calculated from the hybridization intensities and spot information according to the procedures recommended by Agilent Technologies using the Flag criteria in the GeneSpring Software. P = Detected; A = Not detected.","GPL16770","Kohei,,Miyata","slackomit@gmail.com","Obstetrics and Gynecology","Faculty of Medicine","Fukuoka University","7-45-1 Nanakuma, Jonan-ku","Fukuoka","FUkuoka","814-0180","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2108nnn/GSM2108830/suppl/GSM2108830_253118111611_S01_miRNA_107_Sep09_1_3.txt.gz","1347","62","postoperative","Ovarian cancer","serous adenocarcinoma + clear cell carcinoma","IV","blood serum"
"GSM2108831","miRE_2_1","GSM2108831","Public on Mar 19 2017","Apr 05 2016","Mar 19 2017","RNA","1","serum, preoperative","Homo sapiens","tissue: blood serum","collection timepoint: preoperative","diagnosis: Ovarian cancer","histology: endometrioid adenocarcinoma","Stage: IIIc","age: 76","Blood samples were obtained just before operation (preoperative) or after 1 month (postoperative) and centrifuged for 10 minutes at 3,000 r.p.m. to separate serum within 24 hours.","total RNA","Total RNA was isolated from tissues using TRIzol Reagent (nitrogen) and purified using SV Total RNA Isolation System (Promega)","Cy3","cRNA was amplified and labelled using a Low input Quick Amp Labelling Kit (Agilent Technologies).","9606","cRNA was hybridized to a 60K 60-mer oligomicroarray (SurePrint Human miRNA Microarray Release 16.0, 8x60K; Agilent Technologies) according to the manufacturer's instructions.","The hybridized microarray slides were scanned using an Agilent scanner. The relative hybridization intensities and background hybridization values were calculated using Feature Extraction Software version 9.5.1.1 (Agilent Technologies).","Progression free survival ≥ 12 months","The scanned images were analyzed with Feature Extraction Software 9.5.1.1 (Agilent) using default parameters to obtain background subtracted and spatially detrended Processed Signal intensities.  The raw signal intensities and flags for each probe were calculated from the hybridization intensities and spot information according to the procedures recommended by Agilent Technologies using the Flag criteria in the GeneSpring Software. P = Detected; A = Not detected.","GPL16770","Kohei,,Miyata","slackomit@gmail.com","Obstetrics and Gynecology","Faculty of Medicine","Fukuoka University","7-45-1 Nanakuma, Jonan-ku","Fukuoka","FUkuoka","814-0180","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2108nnn/GSM2108831/suppl/GSM2108831_253118111611_S01_miRNA_107_Sep09_1_4.txt.gz","1347","76","preoperative","Ovarian cancer","endometrioid adenocarcinoma","IIIc","blood serum"
"GSM2108832","miRE_2_2","GSM2108832","Public on Mar 19 2017","Apr 05 2016","Mar 19 2017","RNA","1","serum, postoperative","Homo sapiens","tissue: blood serum","collection timepoint: postoperative","diagnosis: Ovarian cancer","histology: endometrioid adenocarcinoma","Stage: IIIc","age: 76","Blood samples were obtained just before operation (preoperative) or after 1 month (postoperative) and centrifuged for 10 minutes at 3,000 r.p.m. to separate serum within 24 hours.","total RNA","Total RNA was isolated from tissues using TRIzol Reagent (nitrogen) and purified using SV Total RNA Isolation System (Promega)","Cy3","cRNA was amplified and labelled using a Low input Quick Amp Labelling Kit (Agilent Technologies).","9606","cRNA was hybridized to a 60K 60-mer oligomicroarray (SurePrint Human miRNA Microarray Release 16.0, 8x60K; Agilent Technologies) according to the manufacturer's instructions.","The hybridized microarray slides were scanned using an Agilent scanner. The relative hybridization intensities and background hybridization values were calculated using Feature Extraction Software version 9.5.1.1 (Agilent Technologies).","Progression free survival ≥ 12 months","The scanned images were analyzed with Feature Extraction Software 9.5.1.1 (Agilent) using default parameters to obtain background subtracted and spatially detrended Processed Signal intensities.  The raw signal intensities and flags for each probe were calculated from the hybridization intensities and spot information according to the procedures recommended by Agilent Technologies using the Flag criteria in the GeneSpring Software. P = Detected; A = Not detected.","GPL16770","Kohei,,Miyata","slackomit@gmail.com","Obstetrics and Gynecology","Faculty of Medicine","Fukuoka University","7-45-1 Nanakuma, Jonan-ku","Fukuoka","FUkuoka","814-0180","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2108nnn/GSM2108832/suppl/GSM2108832_253118111611_S01_miRNA_107_Sep09_2_1.txt.gz","1347","76","postoperative","Ovarian cancer","endometrioid adenocarcinoma","IIIc","blood serum"
"GSM2108833","miRS_9_1","GSM2108833","Public on Mar 19 2017","Apr 05 2016","Mar 19 2017","RNA","1","serum, preoperative","Homo sapiens","tissue: blood serum","collection timepoint: preoperative","diagnosis: Ovarian cancer","histology: clear cell carcinoma","Stage: Ia","age: 61","Blood samples were obtained just before operation (preoperative) or after 1 month (postoperative) and centrifuged for 10 minutes at 3,000 r.p.m. to separate serum within 24 hours.","total RNA","Total RNA was isolated from tissues using TRIzol Reagent (nitrogen) and purified using SV Total RNA Isolation System (Promega)","Cy3","cRNA was amplified and labelled using a Low input Quick Amp Labelling Kit (Agilent Technologies).","9606","cRNA was hybridized to a 60K 60-mer oligomicroarray (SurePrint Human miRNA Microarray Release 16.0, 8x60K; Agilent Technologies) according to the manufacturer's instructions.","The hybridized microarray slides were scanned using an Agilent scanner. The relative hybridization intensities and background hybridization values were calculated using Feature Extraction Software version 9.5.1.1 (Agilent Technologies).","Progression free survival ≥ 12 months","The scanned images were analyzed with Feature Extraction Software 9.5.1.1 (Agilent) using default parameters to obtain background subtracted and spatially detrended Processed Signal intensities.  The raw signal intensities and flags for each probe were calculated from the hybridization intensities and spot information according to the procedures recommended by Agilent Technologies using the Flag criteria in the GeneSpring Software. P = Detected; A = Not detected.","GPL16770","Kohei,,Miyata","slackomit@gmail.com","Obstetrics and Gynecology","Faculty of Medicine","Fukuoka University","7-45-1 Nanakuma, Jonan-ku","Fukuoka","FUkuoka","814-0180","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2108nnn/GSM2108833/suppl/GSM2108833_253118111611_S01_miRNA_107_Sep09_2_2.txt.gz","1347","61","preoperative","Ovarian cancer","clear cell carcinoma","Ia","blood serum"
"GSM2108834","miRS_9_2","GSM2108834","Public on Mar 19 2017","Apr 05 2016","Mar 19 2017","RNA","1","serum, postoperative","Homo sapiens","tissue: blood serum","collection timepoint: postoperative","diagnosis: Ovarian cancer","histology: clear cell carcinoma","Stage: Ia","age: 61","Blood samples were obtained just before operation (preoperative) or after 1 month (postoperative) and centrifuged for 10 minutes at 3,000 r.p.m. to separate serum within 24 hours.","total RNA","Total RNA was isolated from tissues using TRIzol Reagent (nitrogen) and purified using SV Total RNA Isolation System (Promega)","Cy3","cRNA was amplified and labelled using a Low input Quick Amp Labelling Kit (Agilent Technologies).","9606","cRNA was hybridized to a 60K 60-mer oligomicroarray (SurePrint Human miRNA Microarray Release 16.0, 8x60K; Agilent Technologies) according to the manufacturer's instructions.","The hybridized microarray slides were scanned using an Agilent scanner. The relative hybridization intensities and background hybridization values were calculated using Feature Extraction Software version 9.5.1.1 (Agilent Technologies).","Progression free survival ≥ 12 months","The scanned images were analyzed with Feature Extraction Software 9.5.1.1 (Agilent) using default parameters to obtain background subtracted and spatially detrended Processed Signal intensities.  The raw signal intensities and flags for each probe were calculated from the hybridization intensities and spot information according to the procedures recommended by Agilent Technologies using the Flag criteria in the GeneSpring Software. P = Detected; A = Not detected.","GPL16770","Kohei,,Miyata","slackomit@gmail.com","Obstetrics and Gynecology","Faculty of Medicine","Fukuoka University","7-45-1 Nanakuma, Jonan-ku","Fukuoka","FUkuoka","814-0180","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2108nnn/GSM2108834/suppl/GSM2108834_253118113939_S01_miRNA_107_Sep09_1_1.txt.gz","1347","61","postoperative","Ovarian cancer","clear cell carcinoma","Ia","blood serum"
"GSM2108835","miRS_10_1","GSM2108835","Public on Mar 19 2017","Apr 05 2016","Mar 19 2017","RNA","1","serum, preoperative","Homo sapiens","tissue: blood serum","collection timepoint: preoperative","diagnosis: Ovarian cancer","histology: serous adenocarcinoma","Stage: IIIc","age: 62","Blood samples were obtained just before operation (preoperative) or after 1 month (postoperative) and centrifuged for 10 minutes at 3,000 r.p.m. to separate serum within 24 hours.","total RNA","Total RNA was isolated from tissues using TRIzol Reagent (nitrogen) and purified using SV Total RNA Isolation System (Promega)","Cy3","cRNA was amplified and labelled using a Low input Quick Amp Labelling Kit (Agilent Technologies).","9606","cRNA was hybridized to a 60K 60-mer oligomicroarray (SurePrint Human miRNA Microarray Release 16.0, 8x60K; Agilent Technologies) according to the manufacturer's instructions.","The hybridized microarray slides were scanned using an Agilent scanner. The relative hybridization intensities and background hybridization values were calculated using Feature Extraction Software version 9.5.1.1 (Agilent Technologies).","Progression free survival < 12 months","The scanned images were analyzed with Feature Extraction Software 9.5.1.1 (Agilent) using default parameters to obtain background subtracted and spatially detrended Processed Signal intensities.  The raw signal intensities and flags for each probe were calculated from the hybridization intensities and spot information according to the procedures recommended by Agilent Technologies using the Flag criteria in the GeneSpring Software. P = Detected; A = Not detected.","GPL16770","Kohei,,Miyata","slackomit@gmail.com","Obstetrics and Gynecology","Faculty of Medicine","Fukuoka University","7-45-1 Nanakuma, Jonan-ku","Fukuoka","FUkuoka","814-0180","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2108nnn/GSM2108835/suppl/GSM2108835_253118113939_S01_miRNA_107_Sep09_1_2.txt.gz","1347","62","preoperative","Ovarian cancer","serous adenocarcinoma","IIIc","blood serum"
"GSM2108836","miRS_10_2","GSM2108836","Public on Mar 19 2017","Apr 05 2016","Mar 19 2017","RNA","1","serum, postoperative","Homo sapiens","tissue: blood serum","collection timepoint: postoperative","diagnosis: Ovarian cancer","histology: serous adenocarcinoma","Stage: IIIc","age: 62","Blood samples were obtained just before operation (preoperative) or after 1 month (postoperative) and centrifuged for 10 minutes at 3,000 r.p.m. to separate serum within 24 hours.","total RNA","Total RNA was isolated from tissues using TRIzol Reagent (nitrogen) and purified using SV Total RNA Isolation System (Promega)","Cy3","cRNA was amplified and labelled using a Low input Quick Amp Labelling Kit (Agilent Technologies).","9606","cRNA was hybridized to a 60K 60-mer oligomicroarray (SurePrint Human miRNA Microarray Release 16.0, 8x60K; Agilent Technologies) according to the manufacturer's instructions.","The hybridized microarray slides were scanned using an Agilent scanner. The relative hybridization intensities and background hybridization values were calculated using Feature Extraction Software version 9.5.1.1 (Agilent Technologies).","Progression free survival < 12 months","The scanned images were analyzed with Feature Extraction Software 9.5.1.1 (Agilent) using default parameters to obtain background subtracted and spatially detrended Processed Signal intensities.  The raw signal intensities and flags for each probe were calculated from the hybridization intensities and spot information according to the procedures recommended by Agilent Technologies using the Flag criteria in the GeneSpring Software. P = Detected; A = Not detected.","GPL16770","Kohei,,Miyata","slackomit@gmail.com","Obstetrics and Gynecology","Faculty of Medicine","Fukuoka University","7-45-1 Nanakuma, Jonan-ku","Fukuoka","FUkuoka","814-0180","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2108nnn/GSM2108836/suppl/GSM2108836_253118113939_S01_miRNA_107_Sep09_1_3.txt.gz","1347","62","postoperative","Ovarian cancer","serous adenocarcinoma","IIIc","blood serum"
"GSM2108837","miRS_11_1","GSM2108837","Public on Mar 19 2017","Apr 05 2016","Mar 19 2017","RNA","1","serum, preoperative","Homo sapiens","tissue: blood serum","collection timepoint: preoperative","diagnosis: Ovarian cancer","histology: endometrioid adenocarcinoma","Stage: IIIc","age: 70","Blood samples were obtained just before operation (preoperative) or after 1 month (postoperative) and centrifuged for 10 minutes at 3,000 r.p.m. to separate serum within 24 hours.","total RNA","Total RNA was isolated from tissues using TRIzol Reagent (nitrogen) and purified using SV Total RNA Isolation System (Promega)","Cy3","cRNA was amplified and labelled using a Low input Quick Amp Labelling Kit (Agilent Technologies).","9606","cRNA was hybridized to a 60K 60-mer oligomicroarray (SurePrint Human miRNA Microarray Release 16.0, 8x60K; Agilent Technologies) according to the manufacturer's instructions.","The hybridized microarray slides were scanned using an Agilent scanner. The relative hybridization intensities and background hybridization values were calculated using Feature Extraction Software version 9.5.1.1 (Agilent Technologies).","Progression free survival < 12 months","The scanned images were analyzed with Feature Extraction Software 9.5.1.1 (Agilent) using default parameters to obtain background subtracted and spatially detrended Processed Signal intensities.  The raw signal intensities and flags for each probe were calculated from the hybridization intensities and spot information according to the procedures recommended by Agilent Technologies using the Flag criteria in the GeneSpring Software. P = Detected; A = Not detected.","GPL16770","Kohei,,Miyata","slackomit@gmail.com","Obstetrics and Gynecology","Faculty of Medicine","Fukuoka University","7-45-1 Nanakuma, Jonan-ku","Fukuoka","FUkuoka","814-0180","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2108nnn/GSM2108837/suppl/GSM2108837_253118113939_S01_miRNA_107_Sep09_1_4.txt.gz","1347","70","preoperative","Ovarian cancer","endometrioid adenocarcinoma","IIIc","blood serum"
"GSM2108838","miRS_11_2","GSM2108838","Public on Mar 19 2017","Apr 05 2016","Mar 19 2017","RNA","1","serum, postoperative","Homo sapiens","tissue: blood serum","collection timepoint: postoperative","diagnosis: Ovarian cancer","histology: endometrioid adenocarcinoma","Stage: IIIc","age: 70","Blood samples were obtained just before operation (preoperative) or after 1 month (postoperative) and centrifuged for 10 minutes at 3,000 r.p.m. to separate serum within 24 hours.","total RNA","Total RNA was isolated from tissues using TRIzol Reagent (nitrogen) and purified using SV Total RNA Isolation System (Promega)","Cy3","cRNA was amplified and labelled using a Low input Quick Amp Labelling Kit (Agilent Technologies).","9606","cRNA was hybridized to a 60K 60-mer oligomicroarray (SurePrint Human miRNA Microarray Release 16.0, 8x60K; Agilent Technologies) according to the manufacturer's instructions.","The hybridized microarray slides were scanned using an Agilent scanner. The relative hybridization intensities and background hybridization values were calculated using Feature Extraction Software version 9.5.1.1 (Agilent Technologies).","Progression free survival < 12 months","The scanned images were analyzed with Feature Extraction Software 9.5.1.1 (Agilent) using default parameters to obtain background subtracted and spatially detrended Processed Signal intensities.  The raw signal intensities and flags for each probe were calculated from the hybridization intensities and spot information according to the procedures recommended by Agilent Technologies using the Flag criteria in the GeneSpring Software. P = Detected; A = Not detected.","GPL16770","Kohei,,Miyata","slackomit@gmail.com","Obstetrics and Gynecology","Faculty of Medicine","Fukuoka University","7-45-1 Nanakuma, Jonan-ku","Fukuoka","FUkuoka","814-0180","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2108nnn/GSM2108838/suppl/GSM2108838_253118113939_S01_miRNA_107_Sep09_2_1.txt.gz","1347","70","postoperative","Ovarian cancer","endometrioid adenocarcinoma","IIIc","blood serum"
"GSM2108839","miRS_12_1","GSM2108839","Public on Mar 19 2017","Apr 05 2016","Mar 19 2017","RNA","1","serum, preoperative","Homo sapiens","tissue: blood serum","collection timepoint: preoperative","diagnosis: Ovarian cancer","histology: serous adenocarcinoma","Stage: IV","age: 72","Blood samples were obtained just before operation (preoperative) or after 1 month (postoperative) and centrifuged for 10 minutes at 3,000 r.p.m. to separate serum within 24 hours.","total RNA","Total RNA was isolated from tissues using TRIzol Reagent (nitrogen) and purified using SV Total RNA Isolation System (Promega)","Cy3","cRNA was amplified and labelled using a Low input Quick Amp Labelling Kit (Agilent Technologies).","9606","cRNA was hybridized to a 60K 60-mer oligomicroarray (SurePrint Human miRNA Microarray Release 16.0, 8x60K; Agilent Technologies) according to the manufacturer's instructions.","The hybridized microarray slides were scanned using an Agilent scanner. The relative hybridization intensities and background hybridization values were calculated using Feature Extraction Software version 9.5.1.1 (Agilent Technologies).","Progression free survival < 12 months","The scanned images were analyzed with Feature Extraction Software 9.5.1.1 (Agilent) using default parameters to obtain background subtracted and spatially detrended Processed Signal intensities.  The raw signal intensities and flags for each probe were calculated from the hybridization intensities and spot information according to the procedures recommended by Agilent Technologies using the Flag criteria in the GeneSpring Software. P = Detected; A = Not detected.","GPL16770","Kohei,,Miyata","slackomit@gmail.com","Obstetrics and Gynecology","Faculty of Medicine","Fukuoka University","7-45-1 Nanakuma, Jonan-ku","Fukuoka","FUkuoka","814-0180","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2108nnn/GSM2108839/suppl/GSM2108839_253118113939_S01_miRNA_107_Sep09_2_2.txt.gz","1347","72","preoperative","Ovarian cancer","serous adenocarcinoma","IV","blood serum"
"GSM2108840","miRS_12_2","GSM2108840","Public on Mar 19 2017","Apr 05 2016","Mar 19 2017","RNA","1","serum, postoperative","Homo sapiens","tissue: blood serum","collection timepoint: postoperative","diagnosis: Ovarian cancer","histology: serous adenocarcinoma","Stage: IV","age: 72","Blood samples were obtained just before operation (preoperative) or after 1 month (postoperative) and centrifuged for 10 minutes at 3,000 r.p.m. to separate serum within 24 hours.","total RNA","Total RNA was isolated from tissues using TRIzol Reagent (nitrogen) and purified using SV Total RNA Isolation System (Promega)","Cy3","cRNA was amplified and labelled using a Low input Quick Amp Labelling Kit (Agilent Technologies).","9606","cRNA was hybridized to a 60K 60-mer oligomicroarray (SurePrint Human miRNA Microarray Release 16.0, 8x60K; Agilent Technologies) according to the manufacturer's instructions.","The hybridized microarray slides were scanned using an Agilent scanner. The relative hybridization intensities and background hybridization values were calculated using Feature Extraction Software version 9.5.1.1 (Agilent Technologies).","Progression free survival < 12 months","The scanned images were analyzed with Feature Extraction Software 9.5.1.1 (Agilent) using default parameters to obtain background subtracted and spatially detrended Processed Signal intensities.  The raw signal intensities and flags for each probe were calculated from the hybridization intensities and spot information according to the procedures recommended by Agilent Technologies using the Flag criteria in the GeneSpring Software. P = Detected; A = Not detected.","GPL16770","Kohei,,Miyata","slackomit@gmail.com","Obstetrics and Gynecology","Faculty of Medicine","Fukuoka University","7-45-1 Nanakuma, Jonan-ku","Fukuoka","FUkuoka","814-0180","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2108nnn/GSM2108840/suppl/GSM2108840_253118113939_S01_miRNA_107_Sep09_2_3.txt.gz","1347","72","postoperative","Ovarian cancer","serous adenocarcinoma","IV","blood serum"
"GSM2108841","miRS_13_1","GSM2108841","Public on Mar 19 2017","Apr 05 2016","Mar 19 2017","RNA","1","serum, preoperative","Homo sapiens","tissue: blood serum","collection timepoint: preoperative","diagnosis: Ovarian cancer","histology: endometrioid adenocarcinoma","Stage: IIb","age: 54","Blood samples were obtained just before operation (preoperative) or after 1 month (postoperative) and centrifuged for 10 minutes at 3,000 r.p.m. to separate serum within 24 hours.","total RNA","Total RNA was isolated from tissues using TRIzol Reagent (nitrogen) and purified using SV Total RNA Isolation System (Promega)","Cy3","cRNA was amplified and labelled using a Low input Quick Amp Labelling Kit (Agilent Technologies).","9606","cRNA was hybridized to a 60K 60-mer oligomicroarray (SurePrint Human miRNA Microarray Release 16.0, 8x60K; Agilent Technologies) according to the manufacturer's instructions.","The hybridized microarray slides were scanned using an Agilent scanner. The relative hybridization intensities and background hybridization values were calculated using Feature Extraction Software version 9.5.1.1 (Agilent Technologies).","Progression free survival < 12 months","The scanned images were analyzed with Feature Extraction Software 9.5.1.1 (Agilent) using default parameters to obtain background subtracted and spatially detrended Processed Signal intensities.  The raw signal intensities and flags for each probe were calculated from the hybridization intensities and spot information according to the procedures recommended by Agilent Technologies using the Flag criteria in the GeneSpring Software. P = Detected; A = Not detected.","GPL16770","Kohei,,Miyata","slackomit@gmail.com","Obstetrics and Gynecology","Faculty of Medicine","Fukuoka University","7-45-1 Nanakuma, Jonan-ku","Fukuoka","FUkuoka","814-0180","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2108nnn/GSM2108841/suppl/GSM2108841_253118113939_S01_miRNA_107_Sep09_2_4.txt.gz","1347","54","preoperative","Ovarian cancer","endometrioid adenocarcinoma","IIb","blood serum"
"GSM2108842","miRS_14_1","GSM2108842","Public on Mar 19 2017","Apr 05 2016","Mar 19 2017","RNA","1","serum, preoperative","Homo sapiens","tissue: blood serum","collection timepoint: preoperative","diagnosis: Ovarian cancer","histology: serous adenocarcinoma","Stage: IIIc","age: 49","Blood samples were obtained just before operation (preoperative) or after 1 month (postoperative) and centrifuged for 10 minutes at 3,000 r.p.m. to separate serum within 24 hours.","total RNA","Total RNA was isolated from tissues using TRIzol Reagent (nitrogen) and purified using SV Total RNA Isolation System (Promega)","Cy3","cRNA was amplified and labelled using a Low input Quick Amp Labelling Kit (Agilent Technologies).","9606","cRNA was hybridized to a 60K 60-mer oligomicroarray (SurePrint Human miRNA Microarray Release 16.0, 8x60K; Agilent Technologies) according to the manufacturer's instructions.","The hybridized microarray slides were scanned using an Agilent scanner. The relative hybridization intensities and background hybridization values were calculated using Feature Extraction Software version 9.5.1.1 (Agilent Technologies).","Progression free survival < 12 months","The scanned images were analyzed with Feature Extraction Software 9.5.1.1 (Agilent) using default parameters to obtain background subtracted and spatially detrended Processed Signal intensities.  The raw signal intensities and flags for each probe were calculated from the hybridization intensities and spot information according to the procedures recommended by Agilent Technologies using the Flag criteria in the GeneSpring Software. P = Detected; A = Not detected.","GPL16770","Kohei,,Miyata","slackomit@gmail.com","Obstetrics and Gynecology","Faculty of Medicine","Fukuoka University","7-45-1 Nanakuma, Jonan-ku","Fukuoka","FUkuoka","814-0180","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2108nnn/GSM2108842/suppl/GSM2108842_253118113940_S01_miRNA_107_Sep09_1_1.txt.gz","1347","49","preoperative","Ovarian cancer","serous adenocarcinoma","IIIc","blood serum"
"GSM2108843","miRS_15_1","GSM2108843","Public on Mar 19 2017","Apr 05 2016","Mar 19 2017","RNA","1","serum, preoperative","Homo sapiens","tissue: blood serum","collection timepoint: preoperative","diagnosis: Ovarian cancer","histology: serous adenocarcinoma","Stage: IIIc","age: 74","Blood samples were obtained just before operation (preoperative) or after 1 month (postoperative) and centrifuged for 10 minutes at 3,000 r.p.m. to separate serum within 24 hours.","total RNA","Total RNA was isolated from tissues using TRIzol Reagent (nitrogen) and purified using SV Total RNA Isolation System (Promega)","Cy3","cRNA was amplified and labelled using a Low input Quick Amp Labelling Kit (Agilent Technologies).","9606","cRNA was hybridized to a 60K 60-mer oligomicroarray (SurePrint Human miRNA Microarray Release 16.0, 8x60K; Agilent Technologies) according to the manufacturer's instructions.","The hybridized microarray slides were scanned using an Agilent scanner. The relative hybridization intensities and background hybridization values were calculated using Feature Extraction Software version 9.5.1.1 (Agilent Technologies).","Progression free survival ≥ 12 months","The scanned images were analyzed with Feature Extraction Software 9.5.1.1 (Agilent) using default parameters to obtain background subtracted and spatially detrended Processed Signal intensities.  The raw signal intensities and flags for each probe were calculated from the hybridization intensities and spot information according to the procedures recommended by Agilent Technologies using the Flag criteria in the GeneSpring Software. P = Detected; A = Not detected.","GPL16770","Kohei,,Miyata","slackomit@gmail.com","Obstetrics and Gynecology","Faculty of Medicine","Fukuoka University","7-45-1 Nanakuma, Jonan-ku","Fukuoka","FUkuoka","814-0180","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2108nnn/GSM2108843/suppl/GSM2108843_253118113940_S01_miRNA_107_Sep09_1_2.txt.gz","1347","74","preoperative","Ovarian cancer","serous adenocarcinoma","IIIc","blood serum"
"GSM2108844","miRS_15_2","GSM2108844","Public on Mar 19 2017","Apr 05 2016","Mar 19 2017","RNA","1","serum, postoperative","Homo sapiens","tissue: blood serum","collection timepoint: postoperative","diagnosis: Ovarian cancer","histology: serous adenocarcinoma","Stage: IIIc","age: 74","Blood samples were obtained just before operation (preoperative) or after 1 month (postoperative) and centrifuged for 10 minutes at 3,000 r.p.m. to separate serum within 24 hours.","total RNA","Total RNA was isolated from tissues using TRIzol Reagent (nitrogen) and purified using SV Total RNA Isolation System (Promega)","Cy3","cRNA was amplified and labelled using a Low input Quick Amp Labelling Kit (Agilent Technologies).","9606","cRNA was hybridized to a 60K 60-mer oligomicroarray (SurePrint Human miRNA Microarray Release 16.0, 8x60K; Agilent Technologies) according to the manufacturer's instructions.","The hybridized microarray slides were scanned using an Agilent scanner. The relative hybridization intensities and background hybridization values were calculated using Feature Extraction Software version 9.5.1.1 (Agilent Technologies).","Progression free survival ≥ 12 months","The scanned images were analyzed with Feature Extraction Software 9.5.1.1 (Agilent) using default parameters to obtain background subtracted and spatially detrended Processed Signal intensities.  The raw signal intensities and flags for each probe were calculated from the hybridization intensities and spot information according to the procedures recommended by Agilent Technologies using the Flag criteria in the GeneSpring Software. P = Detected; A = Not detected.","GPL16770","Kohei,,Miyata","slackomit@gmail.com","Obstetrics and Gynecology","Faculty of Medicine","Fukuoka University","7-45-1 Nanakuma, Jonan-ku","Fukuoka","FUkuoka","814-0180","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2108nnn/GSM2108844/suppl/GSM2108844_253118113940_S01_miRNA_107_Sep09_1_3.txt.gz","1347","74","postoperative","Ovarian cancer","serous adenocarcinoma","IIIc","blood serum"
"GSM2108845","miRS_18_1","GSM2108845","Public on Mar 19 2017","Apr 05 2016","Mar 19 2017","RNA","1","serum, preoperative","Homo sapiens","tissue: blood serum","collection timepoint: preoperative","diagnosis: Ovarian cancer","histology: endometrioid adenocarcinoma","Stage: IIIc","age: 79","Blood samples were obtained just before operation (preoperative) or after 1 month (postoperative) and centrifuged for 10 minutes at 3,000 r.p.m. to separate serum within 24 hours.","total RNA","Total RNA was isolated from tissues using TRIzol Reagent (nitrogen) and purified using SV Total RNA Isolation System (Promega)","Cy3","cRNA was amplified and labelled using a Low input Quick Amp Labelling Kit (Agilent Technologies).","9606","cRNA was hybridized to a 60K 60-mer oligomicroarray (SurePrint Human miRNA Microarray Release 16.0, 8x60K; Agilent Technologies) according to the manufacturer's instructions.","The hybridized microarray slides were scanned using an Agilent scanner. The relative hybridization intensities and background hybridization values were calculated using Feature Extraction Software version 9.5.1.1 (Agilent Technologies).","Progression free survival < 12 months","The scanned images were analyzed with Feature Extraction Software 9.5.1.1 (Agilent) using default parameters to obtain background subtracted and spatially detrended Processed Signal intensities.  The raw signal intensities and flags for each probe were calculated from the hybridization intensities and spot information according to the procedures recommended by Agilent Technologies using the Flag criteria in the GeneSpring Software. P = Detected; A = Not detected.","GPL16770","Kohei,,Miyata","slackomit@gmail.com","Obstetrics and Gynecology","Faculty of Medicine","Fukuoka University","7-45-1 Nanakuma, Jonan-ku","Fukuoka","FUkuoka","814-0180","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2108nnn/GSM2108845/suppl/GSM2108845_253118113940_S01_miRNA_107_Sep09_2_2.txt.gz","1347","79","preoperative","Ovarian cancer","endometrioid adenocarcinoma","IIIc","blood serum"
"GSM2108846","miRS_19_1","GSM2108846","Public on Mar 19 2017","Apr 05 2016","Mar 19 2017","RNA","1","serum, preoperative","Homo sapiens","tissue: blood serum","collection timepoint: preoperative","diagnosis: Ovarian cancer","histology: serous adenocarcinoma","Stage: IIIc","age: 72","Blood samples were obtained just before operation (preoperative) or after 1 month (postoperative) and centrifuged for 10 minutes at 3,000 r.p.m. to separate serum within 24 hours.","total RNA","Total RNA was isolated from tissues using TRIzol Reagent (nitrogen) and purified using SV Total RNA Isolation System (Promega)","Cy3","cRNA was amplified and labelled using a Low input Quick Amp Labelling Kit (Agilent Technologies).","9606","cRNA was hybridized to a 60K 60-mer oligomicroarray (SurePrint Human miRNA Microarray Release 16.0, 8x60K; Agilent Technologies) according to the manufacturer's instructions.","The hybridized microarray slides were scanned using an Agilent scanner. The relative hybridization intensities and background hybridization values were calculated using Feature Extraction Software version 9.5.1.1 (Agilent Technologies).","Progression free survival < 12 months","The scanned images were analyzed with Feature Extraction Software 9.5.1.1 (Agilent) using default parameters to obtain background subtracted and spatially detrended Processed Signal intensities.  The raw signal intensities and flags for each probe were calculated from the hybridization intensities and spot information according to the procedures recommended by Agilent Technologies using the Flag criteria in the GeneSpring Software. P = Detected; A = Not detected.","GPL16770","Kohei,,Miyata","slackomit@gmail.com","Obstetrics and Gynecology","Faculty of Medicine","Fukuoka University","7-45-1 Nanakuma, Jonan-ku","Fukuoka","FUkuoka","814-0180","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2108nnn/GSM2108846/suppl/GSM2108846_253118113940_S01_miRNA_107_Sep09_2_3.txt.gz","1347","72","preoperative","Ovarian cancer","serous adenocarcinoma","IIIc","blood serum"
"GSM2108847","miRS_19_2","GSM2108847","Public on Mar 19 2017","Apr 05 2016","Mar 19 2017","RNA","1","serum, postoperative","Homo sapiens","tissue: blood serum","collection timepoint: postoperative","diagnosis: Ovarian cancer","histology: serous adenocarcinoma","Stage: IIIc","age: 72","Blood samples were obtained just before operation (preoperative) or after 1 month (postoperative) and centrifuged for 10 minutes at 3,000 r.p.m. to separate serum within 24 hours.","total RNA","Total RNA was isolated from tissues using TRIzol Reagent (nitrogen) and purified using SV Total RNA Isolation System (Promega)","Cy3","cRNA was amplified and labelled using a Low input Quick Amp Labelling Kit (Agilent Technologies).","9606","cRNA was hybridized to a 60K 60-mer oligomicroarray (SurePrint Human miRNA Microarray Release 16.0, 8x60K; Agilent Technologies) according to the manufacturer's instructions.","The hybridized microarray slides were scanned using an Agilent scanner. The relative hybridization intensities and background hybridization values were calculated using Feature Extraction Software version 9.5.1.1 (Agilent Technologies).","Progression free survival < 12 months","The scanned images were analyzed with Feature Extraction Software 9.5.1.1 (Agilent) using default parameters to obtain background subtracted and spatially detrended Processed Signal intensities.  The raw signal intensities and flags for each probe were calculated from the hybridization intensities and spot information according to the procedures recommended by Agilent Technologies using the Flag criteria in the GeneSpring Software. P = Detected; A = Not detected.","GPL16770","Kohei,,Miyata","slackomit@gmail.com","Obstetrics and Gynecology","Faculty of Medicine","Fukuoka University","7-45-1 Nanakuma, Jonan-ku","Fukuoka","FUkuoka","814-0180","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2108nnn/GSM2108847/suppl/GSM2108847_253118113940_S01_miRNA_107_Sep09_2_4.txt.gz","1347","72","postoperative","Ovarian cancer","serous adenocarcinoma","IIIc","blood serum"
"GSM2108848","miRS_23_1","GSM2108848","Public on Mar 19 2017","Apr 05 2016","Mar 19 2017","RNA","1","serum, preoperative","Homo sapiens","tissue: blood serum","collection timepoint: preoperative","diagnosis: Ovarian cancer","histology: endometrioid adenocarcinoma + mucinous adenocarcinoma","Stage: Ic","age: 54","Blood samples were obtained just before operation (preoperative) or after 1 month (postoperative) and centrifuged for 10 minutes at 3,000 r.p.m. to separate serum within 24 hours.","total RNA","Total RNA was isolated from tissues using TRIzol Reagent (nitrogen) and purified using SV Total RNA Isolation System (Promega)","Cy3","cRNA was amplified and labelled using a Low input Quick Amp Labelling Kit (Agilent Technologies).","9606","cRNA was hybridized to a 60K 60-mer oligomicroarray (SurePrint Human miRNA Microarray Release 16.0, 8x60K; Agilent Technologies) according to the manufacturer's instructions.","The hybridized microarray slides were scanned using an Agilent scanner. The relative hybridization intensities and background hybridization values were calculated using Feature Extraction Software version 9.5.1.1 (Agilent Technologies).","Progression free survival ≥ 12 months","The scanned images were analyzed with Feature Extraction Software 9.5.1.1 (Agilent) using default parameters to obtain background subtracted and spatially detrended Processed Signal intensities.  The raw signal intensities and flags for each probe were calculated from the hybridization intensities and spot information according to the procedures recommended by Agilent Technologies using the Flag criteria in the GeneSpring Software. P = Detected; A = Not detected.","GPL16770","Kohei,,Miyata","slackomit@gmail.com","Obstetrics and Gynecology","Faculty of Medicine","Fukuoka University","7-45-1 Nanakuma, Jonan-ku","Fukuoka","FUkuoka","814-0180","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2108nnn/GSM2108848/suppl/GSM2108848_253118113941_S01_miRNA_107_Sep09_2_1.txt.gz","1347","54","preoperative","Ovarian cancer","endometrioid adenocarcinoma + mucinous adenocarcinoma","Ic","blood serum"
"GSM2108849","miRS_24_1","GSM2108849","Public on Mar 19 2017","Apr 05 2016","Mar 19 2017","RNA","1","serum, preoperative","Homo sapiens","tissue: blood serum","collection timepoint: preoperative","diagnosis: Ovarian cancer","histology: immature teratoma","Stage: Ia","age: 21","Blood samples were obtained just before operation (preoperative) or after 1 month (postoperative) and centrifuged for 10 minutes at 3,000 r.p.m. to separate serum within 24 hours.","total RNA","Total RNA was isolated from tissues using TRIzol Reagent (nitrogen) and purified using SV Total RNA Isolation System (Promega)","Cy3","cRNA was amplified and labelled using a Low input Quick Amp Labelling Kit (Agilent Technologies).","9606","cRNA was hybridized to a 60K 60-mer oligomicroarray (SurePrint Human miRNA Microarray Release 16.0, 8x60K; Agilent Technologies) according to the manufacturer's instructions.","The hybridized microarray slides were scanned using an Agilent scanner. The relative hybridization intensities and background hybridization values were calculated using Feature Extraction Software version 9.5.1.1 (Agilent Technologies).","Progression free survival ≥ 12 months","The scanned images were analyzed with Feature Extraction Software 9.5.1.1 (Agilent) using default parameters to obtain background subtracted and spatially detrended Processed Signal intensities.  The raw signal intensities and flags for each probe were calculated from the hybridization intensities and spot information according to the procedures recommended by Agilent Technologies using the Flag criteria in the GeneSpring Software. P = Detected; A = Not detected.","GPL16770","Kohei,,Miyata","slackomit@gmail.com","Obstetrics and Gynecology","Faculty of Medicine","Fukuoka University","7-45-1 Nanakuma, Jonan-ku","Fukuoka","FUkuoka","814-0180","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2108nnn/GSM2108849/suppl/GSM2108849_253118113941_S01_miRNA_107_Sep09_2_2.txt.gz","1347","21","preoperative","Ovarian cancer","immature teratoma","Ia","blood serum"
"GSM2108850","miRS_25_1","GSM2108850","Public on Mar 19 2017","Apr 05 2016","Mar 19 2017","RNA","1","serum, preoperative","Homo sapiens","tissue: blood serum","collection timepoint: preoperative","diagnosis: Ovarian cancer","histology: serous adenocarcinoma","Stage: IIIc","age: 72","Blood samples were obtained just before operation (preoperative) or after 1 month (postoperative) and centrifuged for 10 minutes at 3,000 r.p.m. to separate serum within 24 hours.","total RNA","Total RNA was isolated from tissues using TRIzol Reagent (nitrogen) and purified using SV Total RNA Isolation System (Promega)","Cy3","cRNA was amplified and labelled using a Low input Quick Amp Labelling Kit (Agilent Technologies).","9606","cRNA was hybridized to a 60K 60-mer oligomicroarray (SurePrint Human miRNA Microarray Release 16.0, 8x60K; Agilent Technologies) according to the manufacturer's instructions.","The hybridized microarray slides were scanned using an Agilent scanner. The relative hybridization intensities and background hybridization values were calculated using Feature Extraction Software version 9.5.1.1 (Agilent Technologies).","Progression free survival ≥ 12 months","The scanned images were analyzed with Feature Extraction Software 9.5.1.1 (Agilent) using default parameters to obtain background subtracted and spatially detrended Processed Signal intensities.  The raw signal intensities and flags for each probe were calculated from the hybridization intensities and spot information according to the procedures recommended by Agilent Technologies using the Flag criteria in the GeneSpring Software. P = Detected; A = Not detected.","GPL16770","Kohei,,Miyata","slackomit@gmail.com","Obstetrics and Gynecology","Faculty of Medicine","Fukuoka University","7-45-1 Nanakuma, Jonan-ku","Fukuoka","FUkuoka","814-0180","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2108nnn/GSM2108850/suppl/GSM2108850_253118113941_S01_miRNA_107_Sep09_2_4.txt.gz","1347","72","preoperative","Ovarian cancer","serous adenocarcinoma","IIIc","blood serum"
"GSM2108851","miRS_25_2","GSM2108851","Public on Mar 19 2017","Apr 05 2016","Mar 19 2017","RNA","1","serum, postoperative","Homo sapiens","tissue: blood serum","collection timepoint: postoperative","diagnosis: Ovarian cancer","histology: serous adenocarcinoma","Stage: IIIc","age: 72","Blood samples were obtained just before operation (preoperative) or after 1 month (postoperative) and centrifuged for 10 minutes at 3,000 r.p.m. to separate serum within 24 hours.","total RNA","Total RNA was isolated from tissues using TRIzol Reagent (nitrogen) and purified using SV Total RNA Isolation System (Promega)","Cy3","cRNA was amplified and labelled using a Low input Quick Amp Labelling Kit (Agilent Technologies).","9606","cRNA was hybridized to a 60K 60-mer oligomicroarray (SurePrint Human miRNA Microarray Release 16.0, 8x60K; Agilent Technologies) according to the manufacturer's instructions.","The hybridized microarray slides were scanned using an Agilent scanner. The relative hybridization intensities and background hybridization values were calculated using Feature Extraction Software version 9.5.1.1 (Agilent Technologies).","Progression free survival ≥ 12 months","The scanned images were analyzed with Feature Extraction Software 9.5.1.1 (Agilent) using default parameters to obtain background subtracted and spatially detrended Processed Signal intensities.  The raw signal intensities and flags for each probe were calculated from the hybridization intensities and spot information according to the procedures recommended by Agilent Technologies using the Flag criteria in the GeneSpring Software. P = Detected; A = Not detected.","GPL16770","Kohei,,Miyata","slackomit@gmail.com","Obstetrics and Gynecology","Faculty of Medicine","Fukuoka University","7-45-1 Nanakuma, Jonan-ku","Fukuoka","FUkuoka","814-0180","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2108nnn/GSM2108851/suppl/GSM2108851_253118111612_S01_miRNA_107_Sep09_1_1.txt.gz","1347","72","postoperative","Ovarian cancer","serous adenocarcinoma","IIIc","blood serum"
"GSM2108852","miRN_3","GSM2108852","Public on Mar 19 2017","Apr 05 2016","Mar 19 2017","RNA","1","serum, preoperative","Homo sapiens","tissue: blood serum","collection timepoint: preoperative","diagnosis: Myoma Uteri","histology: normal ovary","Stage: -","age: 53","Blood samples were obtained just before operation (preoperative) or after 1 month (postoperative) and centrifuged for 10 minutes at 3,000 r.p.m. to separate serum within 24 hours.","total RNA","Total RNA was isolated from tissues using TRIzol Reagent (nitrogen) and purified using SV Total RNA Isolation System (Promega)","Cy3","cRNA was amplified and labelled using a Low input Quick Amp Labelling Kit (Agilent Technologies).","9606","cRNA was hybridized to a 60K 60-mer oligomicroarray (SurePrint Human miRNA Microarray Release 16.0, 8x60K; Agilent Technologies) according to the manufacturer's instructions.","The hybridized microarray slides were scanned using an Agilent scanner. The relative hybridization intensities and background hybridization values were calculated using Feature Extraction Software version 9.5.1.1 (Agilent Technologies).","Benign tumor","The scanned images were analyzed with Feature Extraction Software 9.5.1.1 (Agilent) using default parameters to obtain background subtracted and spatially detrended Processed Signal intensities.  The raw signal intensities and flags for each probe were calculated from the hybridization intensities and spot information according to the procedures recommended by Agilent Technologies using the Flag criteria in the GeneSpring Software. P = Detected; A = Not detected.","GPL16770","Kohei,,Miyata","slackomit@gmail.com","Obstetrics and Gynecology","Faculty of Medicine","Fukuoka University","7-45-1 Nanakuma, Jonan-ku","Fukuoka","FUkuoka","814-0180","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2108nnn/GSM2108852/suppl/GSM2108852_253118111612_S01_miRNA_107_Sep09_1_2.txt.gz","1347","53","preoperative","Myoma Uteri","normal ovary","-","blood serum"
"GSM2108853","miRN_4","GSM2108853","Public on Mar 19 2017","Apr 05 2016","Mar 19 2017","RNA","1","serum, preoperative","Homo sapiens","tissue: blood serum","collection timepoint: preoperative","diagnosis: Myoma Uteri","histology: normal ovary","Stage: -","age: 54","Blood samples were obtained just before operation (preoperative) or after 1 month (postoperative) and centrifuged for 10 minutes at 3,000 r.p.m. to separate serum within 24 hours.","total RNA","Total RNA was isolated from tissues using TRIzol Reagent (nitrogen) and purified using SV Total RNA Isolation System (Promega)","Cy3","cRNA was amplified and labelled using a Low input Quick Amp Labelling Kit (Agilent Technologies).","9606","cRNA was hybridized to a 60K 60-mer oligomicroarray (SurePrint Human miRNA Microarray Release 16.0, 8x60K; Agilent Technologies) according to the manufacturer's instructions.","The hybridized microarray slides were scanned using an Agilent scanner. The relative hybridization intensities and background hybridization values were calculated using Feature Extraction Software version 9.5.1.1 (Agilent Technologies).","Benign tumor","The scanned images were analyzed with Feature Extraction Software 9.5.1.1 (Agilent) using default parameters to obtain background subtracted and spatially detrended Processed Signal intensities.  The raw signal intensities and flags for each probe were calculated from the hybridization intensities and spot information according to the procedures recommended by Agilent Technologies using the Flag criteria in the GeneSpring Software. P = Detected; A = Not detected.","GPL16770","Kohei,,Miyata","slackomit@gmail.com","Obstetrics and Gynecology","Faculty of Medicine","Fukuoka University","7-45-1 Nanakuma, Jonan-ku","Fukuoka","FUkuoka","814-0180","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2108nnn/GSM2108853/suppl/GSM2108853_253118111612_S01_miRNA_107_Sep09_1_3.txt.gz","1347","54","preoperative","Myoma Uteri","normal ovary","-","blood serum"
"GSM2108854","miRN_5","GSM2108854","Public on Mar 19 2017","Apr 05 2016","Mar 19 2017","RNA","1","serum, preoperative","Homo sapiens","tissue: blood serum","collection timepoint: preoperative","diagnosis: Myoma Uteri","histology: normal ovary","Stage: -","age: 53","Blood samples were obtained just before operation (preoperative) or after 1 month (postoperative) and centrifuged for 10 minutes at 3,000 r.p.m. to separate serum within 24 hours.","total RNA","Total RNA was isolated from tissues using TRIzol Reagent (nitrogen) and purified using SV Total RNA Isolation System (Promega)","Cy3","cRNA was amplified and labelled using a Low input Quick Amp Labelling Kit (Agilent Technologies).","9606","cRNA was hybridized to a 60K 60-mer oligomicroarray (SurePrint Human miRNA Microarray Release 16.0, 8x60K; Agilent Technologies) according to the manufacturer's instructions.","The hybridized microarray slides were scanned using an Agilent scanner. The relative hybridization intensities and background hybridization values were calculated using Feature Extraction Software version 9.5.1.1 (Agilent Technologies).","Benign tumor","The scanned images were analyzed with Feature Extraction Software 9.5.1.1 (Agilent) using default parameters to obtain background subtracted and spatially detrended Processed Signal intensities.  The raw signal intensities and flags for each probe were calculated from the hybridization intensities and spot information according to the procedures recommended by Agilent Technologies using the Flag criteria in the GeneSpring Software. P = Detected; A = Not detected.","GPL16770","Kohei,,Miyata","slackomit@gmail.com","Obstetrics and Gynecology","Faculty of Medicine","Fukuoka University","7-45-1 Nanakuma, Jonan-ku","Fukuoka","FUkuoka","814-0180","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2108nnn/GSM2108854/suppl/GSM2108854_253118111612_S01_miRNA_107_Sep09_1_4.txt.gz","1347","53","preoperative","Myoma Uteri","normal ovary","-","blood serum"
"GSM2108855","miRN_6","GSM2108855","Public on Mar 19 2017","Apr 05 2016","Mar 19 2017","RNA","1","serum, preoperative","Homo sapiens","tissue: blood serum","collection timepoint: preoperative","diagnosis: Myoma Uteri","histology: normal ovary","Stage: -","age: 55","Blood samples were obtained just before operation (preoperative) or after 1 month (postoperative) and centrifuged for 10 minutes at 3,000 r.p.m. to separate serum within 24 hours.","total RNA","Total RNA was isolated from tissues using TRIzol Reagent (nitrogen) and purified using SV Total RNA Isolation System (Promega)","Cy3","cRNA was amplified and labelled using a Low input Quick Amp Labelling Kit (Agilent Technologies).","9606","cRNA was hybridized to a 60K 60-mer oligomicroarray (SurePrint Human miRNA Microarray Release 16.0, 8x60K; Agilent Technologies) according to the manufacturer's instructions.","The hybridized microarray slides were scanned using an Agilent scanner. The relative hybridization intensities and background hybridization values were calculated using Feature Extraction Software version 9.5.1.1 (Agilent Technologies).","Benign tumor","The scanned images were analyzed with Feature Extraction Software 9.5.1.1 (Agilent) using default parameters to obtain background subtracted and spatially detrended Processed Signal intensities.  The raw signal intensities and flags for each probe were calculated from the hybridization intensities and spot information according to the procedures recommended by Agilent Technologies using the Flag criteria in the GeneSpring Software. P = Detected; A = Not detected.","GPL16770","Kohei,,Miyata","slackomit@gmail.com","Obstetrics and Gynecology","Faculty of Medicine","Fukuoka University","7-45-1 Nanakuma, Jonan-ku","Fukuoka","FUkuoka","814-0180","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2108nnn/GSM2108855/suppl/GSM2108855_253118111612_S01_miRNA_107_Sep09_2_1.txt.gz","1347","55","preoperative","Myoma Uteri","normal ovary","-","blood serum"
"GSM2108856","miRN_7","GSM2108856","Public on Mar 19 2017","Apr 05 2016","Mar 19 2017","RNA","1","serum, preoperative","Homo sapiens","tissue: blood serum","collection timepoint: preoperative","diagnosis: Paraovarian cyst","histology: normal ovary","Stage: -","age: 62","Blood samples were obtained just before operation (preoperative) or after 1 month (postoperative) and centrifuged for 10 minutes at 3,000 r.p.m. to separate serum within 24 hours.","total RNA","Total RNA was isolated from tissues using TRIzol Reagent (nitrogen) and purified using SV Total RNA Isolation System (Promega)","Cy3","cRNA was amplified and labelled using a Low input Quick Amp Labelling Kit (Agilent Technologies).","9606","cRNA was hybridized to a 60K 60-mer oligomicroarray (SurePrint Human miRNA Microarray Release 16.0, 8x60K; Agilent Technologies) according to the manufacturer's instructions.","The hybridized microarray slides were scanned using an Agilent scanner. The relative hybridization intensities and background hybridization values were calculated using Feature Extraction Software version 9.5.1.1 (Agilent Technologies).","Benign tumor","The scanned images were analyzed with Feature Extraction Software 9.5.1.1 (Agilent) using default parameters to obtain background subtracted and spatially detrended Processed Signal intensities.  The raw signal intensities and flags for each probe were calculated from the hybridization intensities and spot information according to the procedures recommended by Agilent Technologies using the Flag criteria in the GeneSpring Software. P = Detected; A = Not detected.","GPL16770","Kohei,,Miyata","slackomit@gmail.com","Obstetrics and Gynecology","Faculty of Medicine","Fukuoka University","7-45-1 Nanakuma, Jonan-ku","Fukuoka","FUkuoka","814-0180","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2108nnn/GSM2108856/suppl/GSM2108856_253118111612_S01_miRNA_107_Sep09_2_2.txt.gz","1347","62","preoperative","Paraovarian cyst","normal ovary","-","blood serum"
